KENNEDY CAPITAL MANAGEMENT LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,733,332
-5.6%
45,626
-37.5%
0.05%
-9.3%
Q3 2022$1,836,000
-23.2%
73,050
-7.2%
0.05%
-19.4%
Q2 2022$2,391,000
-8.3%
78,681
-1.1%
0.07%
+8.1%
Q1 2022$2,607,000
+24.3%
79,579
+0.1%
0.06%
+40.9%
Q4 2021$2,097,000
-70.4%
79,524
+12.9%
0.04%
-72.3%
Q3 2021$7,084,000
-29.8%
70,407
-1.2%
0.16%
-26.7%
Q2 2021$10,090,000
+35.6%
71,290
-4.5%
0.22%
+44.7%
Q1 2021$7,441,000
-16.4%
74,629
+3.6%
0.15%
-25.4%
Q4 2020$8,901,000
+25.5%
72,004
-1.1%
0.20%
-1.0%
Q3 2020$7,091,000
-38.1%
72,792
-0.9%
0.20%
-38.9%
Q2 2020$11,459,000
+6.6%
73,448
-1.4%
0.33%
-15.9%
Q1 2020$10,753,000
-30.7%
74,501
-1.9%
0.40%
+4.2%
Q4 2019$15,523,000
+17.0%
75,932
-54.1%
0.38%
+15.2%
Q3 2019$13,273,000
-26.4%
165,314
-13.5%
0.33%
-23.3%
Q2 2019$18,041,000
-46.1%
191,209
-51.2%
0.43%
+8.3%
Q1 2019$33,462,000
+179.4%
391,512
+83.4%
0.40%
+33.3%
Q4 2018$11,978,000
-46.7%
213,515
-22.3%
0.30%
-28.9%
Q3 2018$22,465,000
+99.0%
274,772
-14.9%
0.42%
+99.0%
Q2 2018$11,288,000
+130.9%
322,801
+35.5%
0.21%
+121.1%
Q1 2018$4,888,000
-30.9%
238,310
-4.6%
0.10%
-25.2%
Q4 2017$7,075,000
+11.4%
249,806
+22.3%
0.13%
+10.4%
Q3 2017$6,352,000204,2600.12%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders